Clinical trial
Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
NCT01411696 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- March 31, 2012
- Enrollment
- 289 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.